BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7541640)

  • 21. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.
    Nucifora G; Begy CR; Erickson P; Drabkin HA; Rowley JD
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7784-8. PubMed ID: 8395054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
    Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.
    Rhoades KL; Hetherington CJ; Rowley JD; Hiebert SW; Nucifora G; Tenen DG; Zhang DE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11895-900. PubMed ID: 8876234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.
    Barseguian K; Lutterbach B; Hiebert SW; Nickerson J; Lian JB; Stein JL; van Wijnen AJ; Stein GS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15434-9. PubMed ID: 12427969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
    Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD
    Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.
    Miyamoto T; Weissman IL; Akashi K
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7521-6. PubMed ID: 10861016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission.
    Guerrasio A; Rosso C; Martinelli G; Lo Coco F; Pampinella M; Santoro A; Lanza C; Allione B; Resegotti L; Saglio G
    Br J Haematol; 1995 Jun; 90(2):364-8. PubMed ID: 7794758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ETO domain is necessary for the developmental abnormalities associated with AML1-ETO expression in the hematopoietic stem cell compartment in vivo.
    de Guzman CG; Johnson A; Klug CA
    Blood Cells Mol Dis; 2003; 30(2):201-6. PubMed ID: 12732184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts.
    Sacchi N; Nisson PE; Watkins PC; Faustinella F; Wijsman J; Hagemeijer A
    Genes Chromosomes Cancer; 1994 Dec; 11(4):226-36. PubMed ID: 7533526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the Children's Oncology Group.
    LaFiura KM; Edwards H; Taub JW; Matherly LH; Fontana JA; Mohamed AN; Ravindranath Y; Ge Y;
    Oncogene; 2008 Aug; 27(36):4933-42. PubMed ID: 18469864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.
    Tsukamoto N; Karasawa M; Tanaka Y; Yokohama A; Uchiumi H; Matsushima T; Murakami H; Nojima Y
    Int J Hematol; 2003 Nov; 78(4):362-9. PubMed ID: 14686496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
    Yergeau DA; Hetherington CJ; Wang Q; Zhang P; Sharpe AH; Binder M; Marín-Padilla M; Tenen DG; Speck NA; Zhang DE
    Nat Genet; 1997 Mar; 15(3):303-6. PubMed ID: 9054947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation.
    Downing JR; Head DR; Curcio-Brint AM; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Drabkin HA; Willman C; Theil KS
    Blood; 1993 Jun; 81(11):2860-5. PubMed ID: 8499624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission.
    Satake N; Maseki N; Kozu T; Sakashita A; Kobayashi H; Sakurai M; Ohki M; Kaneko Y
    Br J Haematol; 1995 Dec; 91(4):892-8. PubMed ID: 8547135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
    Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid leukemia with t(8;21) irrespective of disease phase.
    Saunders MJ; Tobal K; Keeney S; Liu Yin JA
    Leukemia; 1996 Jul; 10(7):1139-42. PubMed ID: 8683993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M; Stock M; Berg T; Lübbert M
    Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of MTG8 in leukemogenesis.
    Kozu T; Komori A; Sueoka E; Fujiki H; Kaneko Y; Matsui T; Uehara T; Seino Y; Ishii M
    Leukemia; 1997 Apr; 11 Suppl 3():297-8. PubMed ID: 9209371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
    Zhang Y; Strissel P; Strick R; Chen J; Nucifora G; Le Beau MM; Larson RA; Rowley JD
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3070-5. PubMed ID: 11867721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia.
    Miyoshi H; Ohira M; Shimizu K; Mitani K; Hirai H; Imai T; Yokoyama K; Soeda E; Ohki M
    Nucleic Acids Res; 1995 Jul; 23(14):2762-9. PubMed ID: 7651838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.